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During more than 2.5 billion years of
evolution, it is likely that cytochrome P450
(CYP) genes first appeared in prokaryotes
and then in early eukaryotes to carry out
important roles in critical life processes; fol-
lowing the divergence of plants and animals
some 1.8 billion years ago and especially
after the radiation of innumerable phyla
about 543 million years ago, animal CYP
enzymes then took on the functions of
metabolizing many plant products and other
environmental chemicals that were con-
sumed, inhaled, or in contact with the ani-
mal’s skin (Nebert 1997; Nebert and Dieter
2000). For some CYP forms, evidence
clearly indicates that their principal func-
tions include the oxidative metabolism of
endogenous molecules such as steroids,
sterols, bile acids, retinoic acid, and many of
the >100 eicosanoids (Nebert and Russell
2002). In addition, it is likely there are still
many endogenous roles of CYP of which we
remain ignorant. For instance, although
CYP1A1/1A2/1B1 induction is well estab-
lished in the metabolism of pro-carcinogenic
polycyclic aromatic hydrocarbons and aryl-
amines, these three enzymes are suggested to
have pivotal functions in degrading the
putative endogenous ligand(s) of the aryl
hydrocarbon (AH) receptor and perhaps
participate in apoptosis and cell-cycle regula-
tion (Nebert et al. 2000b).
Among the few abundant CYPs that are
expressed constitutively in mammalian liver,
CYP1A2 carries out several known endoge-
nous functions such as uroporphyrinogen
and melatonin oxidation and the 2- and
especially 4-hydroxylations of estradiol
(Nebert and Russell 2002). The Cyp1a2(–/–)
knockout mouse, however, has no apparent
overt phenotype or problems with viability
or fertility (Liang et al. 1996). These ﬁnd-
ings suggest that, in the absence of a foreign
chemical, the expression of CYP1A2 might
be redundant. In humans, CYP1A2-medi-
ated activity varies >60-fold between indi-
viduals (Nebert 1997; Eaton et al. 1995;
Nebert et al. 1996; Dorne et al. 2001), also
with no overt phenotype; most of the varia-
tion does not depend on lifestyle or nutri-
tion but is likely to be genetically
determined (Le Marchand et al. 1997). It
seems unlikely, however, that high constitu-
tive CYP1A2 expression in mammalian liver
continues without a particular purpose,
whereas CYP1A1 expression occurs only
under conditions of ligand-activation of the
AH receptor (Nebert et al. 2000b).
CYP1A2 is absent in fish but present in
birds and mammals, suggesting that
between 380 million and 320 million years
ago this gene arose from CYP1A1 by way of
a duplication event; most likely, the dupli-
cated CYP1A2 gene “drifted” from CYP1A1
until it became involved in one or more crit-
ical life functions or in the metabolism of
dietary components or environmental chem-
icals, such that the animal gained a repro-
ductive or survival advantage (Heilmann et
al. 1988; Nebert et al. 1991).
The development of mice with disrup-
tions in specific genes allows testing of
hypotheses that various CYPs might have
physiologic roles not yet identiﬁed (Nebert
and Duffy 1997). Many knockout mouse
lines show profoundly altered phenotypes
from normal, including lethality during
embryogenesis if the gene participates in a
nonredundant component of a metabolic
pathway. In one of our laboratories we have
been particularly interested in the effect of
knocking out members of the Cyp1a family.
For example, Cyp1a1(–/–) knockout mice
are fertile and healthy and show no appar-
ent changes in the activity or expression of
other genes in the [Ah] gene battery, includ-
ing Cyp1a2, following administration of
AH receptor ligands (Dalton et al. 2000a).
Similarly, the untreated or inducer-treated
Cyp1a2(–/–) null mouse shows no apparent
changes in expression of other genes in the
[Ah] gene battery, including Cyp1a1 (Liang
et al. 1997). On the other hand, both
Cyp1a1(–/–1) and Cyp1a2(–/–) lines show
modified biochemical responses to foreign
chemicals (Liang et al. 1996; Dalton et al.
2000a; Liang et al. 1997; Pineau et al.
1995; Buters et al. 1996; Peters et al. 1999;
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Several forms of cytochrome P450 (CYP) appear to metabolize principally pharmaceutical agents,
as well as other dietary and plant chemicals. Other CYP forms have major roles in steroid, sterol,
and bile acid metabolism. CYP1A2 expression is constitutively high in mouse liver and is well
known for metabolizing several drugs and many procarcinogens to reactive intermediates that can
cause toxicity or cancer. CYP1A2 is also known to carry out several endogenous functions such as
uroporphyrinogen and melatonin oxidation and the 2- and 4-hydroxylations of estradiol. We
have used cDNA microarray analysis of the untreated Cyp1a2(–/–) knockout mouse to search for
changes in gene expression that might indicate important intrinsic roles for this enzyme. For 15
of the up- or downregulated genes, these increases or decreases were corroborated by reverse-tran-
scription real-time polymerase chain reaction. Other than upregulation of the Hprt gene (used in
the selection procedure for disrupting the Cyp1a2 gene), we found several genes upregulated that
are associated with cell-cycle regulation and lipid metabolism. Besides Cyp1a2, the gene exhibit-
ing the greatest downregulation was Igfbp1 (insulin-like growth factor binding protein-1), show-
ing only 12% expression of that in the Cyp1a2(+/+) wild-type liver. Recurrent themes between
both up- and downregulated genes include cell-cycle control, insulin action, lipogenesis, and fatty
acid and cholesterol biosynthetic pathways. Histologically, the Cyp1a2(–/–) mouse exhibited an
approximately 50% decrease in lipid stored in hepatocytes, and 50% increase in lipid present in
interstitial fat-storing cells compared with that in the Cyp1a2(+/+) wild-type. These data suggest
that the CYP1A2 enzyme might perform additional hepatic endogenous functions heretofore not
appreciated. Key words: cDNA expression library; cell cycle control; cholesterol biosynthesis;
CYP1A2, endogenous substrate metabolism; CYP1A2, foreign chemical metabolism;
Cyp1a2(–/–) knockout mouse; fatty acid biosynthesis; insulin action; lipogenesis. Environ Health
Perspect 111:855–861 (2003). doi:10.1289/txg.5925 available via http://dx.doi.org/ [Online
20 November 2002]
Toxicogenomics | ArticleKimura et al. 1999; Shertzer et al. 2002).
Cyp1a2(–/–) mice metabolize zoxazo-
lamine, caffeine, and phenacetin less exten-
sively than Cyp1a2(+/+) wild-type mice and
are more susceptible to some aspects of toxi-
city of these drugs (Liang et al. 1996; Buters 
et al. 1996; Peters et al. 1999). On the con-
trary, Cyp1a2-null mice are unexpectedly
protected from 4-aminobiphenyl-induced
tumorigenesis (Kimura et al. 1999) and 
4-aminobiphenyl-induced methemoglo-
binemia (Shertzer et al. 2002). Cyp1a2(–/–)
mice also appear to be completely protected
from hepatic uroporphyria caused by
dioxin, hexachlorobenzene, and iron over-
load, although metabolism of these chemi-
cals does not seem to be involved in the
mechanism of their toxicity (Sinclair et al.
1998; Sinclair et al. 2000; Smith et al.
2001); in these cases, CYP1A2 appears to
be functioning in a mode that does not
involve production of a reactive metabolite.
Other studies suggest that CYP1A2 might
have a role in bilirubin metabolism
(Zaccaro et al. 2001). It has been proposed
that CYP1A1 metabolizes an endogenous
substrate that modulates AH receptor-
mediated gene expression and that, in the
liver, CYP1A2 can take over this role
(Nebert et al. 2000b). Since there is no con-
stitutive expression of Cyp1a1 in the liver, it
would be interesting to investigate whether
nonpathologic changes in hepatic metabo-
lism might occur in the complete absence of
constitutive CYP1A2. We have thus used
cDNA microarrays to compare hepatic gene
expression differences between the
untreated Cyp1a2(–/–) knockout and the
Cyp1a2(+/+) wild-type mouse. 
Materials and Methods 
The Cyp1a2(–/–) mouse line. Knockout
mice had been generated by removing por-
tions of exons 2 and all of exons 3–5 of the
Cyp1a2 gene; insertion of the Hprt mini-
gene cassette was used for selection in
embryonic stem (ES) cell cultures (Liang et
al. 1996). Although the mice were origi-
nally generated from a mixture of the
C57BL/6J and 129/J inbred strains, the
Cyp1a2(–/–) genotype was subsequently
backcrossed into the C57BL/6J strain to a
theoretical level of >99.8%; if the mouse
genome contains 40,000 genes, this would
mean that the Cyp1a2(–/–) line in the
Nebert mouse colony should have fewer
than about 80 genes that might be
expected to be of 129/J origin (Nebert 
et al. 2000a). For this reason, C57BL/6J
mice from the Jackson Laboratory (Bar
Harbor, ME, USA) were used as the
Cyp1a2(+/+) controls in the present experi-
ments. We used untreated males, approxi-
mately 10 weeks of age, in the microarray
studies; females and males were compared
in the histologic studies.
Mouse EST clones and preparation
of cDNA. The arrays comprised 4,246
mouse expressed-sequence-tag (EST)
clones (2,783 individual Genbank clusters).
Two-thirds of the clones were obtained
from the I.M.A.G.E. collections held at the
MRC Human Gene Mapping Project
(http://www.hgmp.mrc.ac.uk/). The remain-
ing one-third of the EST clones were
obtained from Research Genetics (RG9 set;
http://www.resgen.com). All clones described
in this article were verified by sequence
analysis. cDNA from the EST was obtained
via polymerase chain reaction (PCR) ampli-
ﬁcation using plasmid-speciﬁc primers. The
PCR products were separated by elec-
trophoresis on agarose gels to ensure that
only a single product was obtained for each
clone. The reaction products were precipi-
tated and prepared for array, using methods
described (DeRisi et al. 1997; Eisen and
Brown 1999).
Printing of the arrays. Arrays were
printed on poly-L-lysine-coated slides, UV-
cross-linked, and blocked prior to use
(DeRisi et al. 1997; Eisen and Brown
1999; Turton et al. 2001). The arrays were
printed using an arrayer built essentially
according to the Stanford designs (cf.
http://www.le.ac.uk/cmht/microarray_lab/
Home.htm). The center-to-center distance
of the features was 210 µm, and each
feature was 90–100 µm in diameter.
Labeling and hybridizations. Total
RNA was prepared from mouse liver by
sedimentation through CsCl. The RNA of
ﬁve individual Cyp1a2(+/+) wild-type mice
and five individual Cyp1a2(–/–) knockout
mice were each separately labeled with both
Cy3 dUTP and Cy5 dUTP. RNA labeling
was carried out essentially as described
(DeRisi et al. 1997; Eisen and Brown
1999; Turton et al. 2001). Priming was
achieved with the oligo dT(25), using 4 µg
of the oligo with 50 µg of total RNA. After
denaturation at 70°C for 8 min, annealing
was allowed to occur as the temperature fell
to 42°C over 30 min. At this point, dNTPs
(Pharmacia/Amersham, Bucks, UK) were
added to final concentrations of 0.5 mM,
with the exception of dTTP, which was at
0.2 mM. The desired Cy-labeled dUTP
(Pharmacia/Amersham) was then added to
a final concentration of 0.1 mM. We
used the 1X first-strand buffer (Gibco/
Invitrogen, Paisley, Scottland). RNAsin
(20 U) was added to the reaction.
Transcription was initiated by addition of
100 U of Superscript II (Gibco/Invitrogen)
and allowed to proceed for 1 hr at 42°C
before addition of a second 100 U of
Superscript II and another 1-hr incubation
at 42°C. RNA was removed from the syn-
thesized cDNA by addition of NaOH/
EDTA/sodium dodecyl sulfate (SDS) to
final concentrations of 0.195 M/10
mM/0.22%, respectively, and incubated at
70°C for 10 min. The reaction was neutral-
ized by addition of HCl and buffered to
pH 7.5 by the addition of Tris–HCl. The
reaction products were puriﬁed by passage
through a Centri-Sep column (Princeton
Separations, Inc., Adelphi, NJ, USA),
dried, and resuspended in hybridization
buffer. Prior to hybridization, the samples
were heated to 100°C for 2 min, then at
42°C for at least 30 min.
Hybridizations were conducted in
humidified chambers at 42°C for approxi-
mately 16 hr. The hybridization buffer
consisted of 50% deionized formamide/
0.5% SDS/6× SSPE (1 M NaCl/0.33 mM
NaH2PO4/6.6 mM EDTA, pH 7.4) and
2.5× Denhardt’s/0.06 µg/µL of polyA(80)/
0.66 µg/µL human Cot 1 DNA/0.27
µg/µL yeast tRNA. The arrays were washed
in 1.0× SSC (0.15 M NaCl/0.015 M Na
citrate, pH 7.0), 0.03% SDS for 10 min,
then washed in 0.2× SSC for 5 min, and a
ﬁnal wash in 0.05× SSC for 5 min at room
temperature. The slides were dried by cen-
trifugation at 800 rpm for 5 min. For each
pair of Cyp1a2(+/+) and Cyp1a2(–/–) mice,
the Cy3-labeled cDNA product was
hybridized against the Cy5-labeled cDNA
product, and vice versa—giving 10 separate
hybridizations from the five pairs of
animals being compared.
Analysis of fluorescence and data
processing. The fluorescence of all the fea-
tures on the slides was measured using the
GenePix software (version 3.0.0.85; Axon
Instruments, Union City, CA, USA).
Feature sizes were determined using the
inbuilt automated parameters in the first
instance and then adjusted manually where
appropriate. The ﬂuorescence of each pixel
within the feature was determined, and the
median ﬂuorescence of these pixel measure-
ments was taken as the measure of ﬂuores-
cence for the whole feature. The local
background fluorescence was measured
using the default GenePix parameters. The
raw feature data for each channel were
globally centered by reference to the
median fluorescence of the whole feature
set for that channel. The changes in gene
expression obtained are shown as means ±
standard deviations of the ratio between
the Cy3 and Cy5 channels for 10 pairs
of hybridizations. 
Reverse-transcription real-time PCR
using SYBR Green. For an alternative esti-
mation of changes in gene expression, the
relative mRNA levels of genes of interest
were determined by comparison with a
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(Actb). The primers used (Table 4) were
designed to cross exon-exon boundaries to
eliminate the detection of any contaminat-
ing genomic DNA.
In the ﬁrst step, cDNA was synthesized
from total RNA. A 1,450-µL master mix
was made up as follows: 200 µL PCR
buffer, (catalog no. Y02028; Gibco/
Invitrogen); 100 µL MgCl2 (50 mM); 20
µL each of dATP, dCTP, dGTP, dTTP
(all 100 mM); 19.8 µL random hexamers
(catalog no. 27-2166-01; Amersham; 90
OD U/mL); dithiothreitol (Gibco
400147); and 1,030.2 µL water. For cDNA
synthesis, a 40-µL reaction contained: 29
µl of the master mix; 8 µL total RNA (400
ng); 40 U RNAsin (catalog no. N211B;
Promega, Southampton, UK); and 400 U
SuperScript II reverse transcriptase (Gibco/
Invitrogen). The mixture was heated for 10
min at 23°C, then for 30 min at 42°C, and
finally for 10 min at 99°C. In the second
step, 1 µL of the product of the cDNA syn-
thesis (from 10 ng RNA), or a non-tem-
plate control, was incubated with 24 µL
SYBR Green PCR Master Mix (part no.
4309155; Applied Biosystems, Warrenton,
UK) containing 900 nM forward primer
and 300 nM reverse primer in an ABI
PRISM 7700 Sequence Detection System.
The thermal-cycler protocol was stage one,
50°C for 2 min; stage two, 95°C for 10
min; stage three, 40 cycles at 95°C for 15
sec and 60°C for 1 min. For every sample
of Cyp1a2(+/+) and Cyp1a2(–/–) liver, the
relative level of each gene examined was
compared with that for β-actin. A compari-
son was then made for the expression of
the gene between the wild-type and the
knockout animal.
Histologic analysis of liver. Liver was
prepared for routine light- and electron-
microscopic histology and morphometry
(Dalton et al. 2000b). Twenty-eight
Cyp1a2(–/–) and 28 Cyp1a2(+/+) mice
were used, with equal numbers of males
and females (8–10 weeks of age). Phase-
contrast microscopy of toluidine blue-
stained 1.5-micron–thick plastic sections
was used to quantify the relative amounts
of parenchymal and interstitial cells and to
determine the volume density of hepato-
cyte and of interstitial fat, glycogen pools,
and necrosis. A grid of 75 intersections
was visualized over the light-microscopic
image using a Zeiss Photomik light-
microscopy (Carl Zeiss GmbH, Vienna,
Austria) and camera lucida, and the num-
ber of positive intersections lying over
hepatocytes, interstitial cells, lipid, and
glycogen was counted. The volume density
(Vd) of each parameter was determined by
dividing those values by the total number
of positive intersections lying over the
entire tissue.
Statistical analysis of microarray data
was performed using the two-tailed paired
t-test, taking the reference ratio for the
population as 1.0 and comparing this with
the ratio change. Means and standard-
errors-of-the-mean were obtained from
morphometric data, using the General
Linear Model of SAS 6.1 (SAS Institute,
Inc., Cary, NC, USA). A p <0.05 value was
regarded as statistically signiﬁcant.
Results 
cDNA expression microarray. To investi-
gate potential biochemical phenotypic dif-
ferences, we compared constitutive hepatic
gene expression of Cyp1a2(–/–) mice with
that of aged-matched Cyp1a2(+/+) mice,
using cDNA microarrays. Labeling of
samples with both Cy3 and Cy5 dyes
(reverse-labeling) was performed to take
into account any methodologic bias. Our
information was thus based on 10 separate
hybridizations from five mice. Although it
is often customary in array work to use an
arbitrary cut-off at a 2-fold change in
expression, we believe that <2-fold alter-
ations can be important in critical-life-
process pathways and therefore chose to list
all expressions that had changed signifi-
cantly as assessed statistically at p <0.05
(Tables 1, 2). Only a relatively few genes
were detected that exhibited signiﬁcant up-
or downregulation. With the particular
array used, we found a greater number of
downregulated than upregulated genes in
the Cyp1a2(–/–) mouse.
The >5-fold elevation in Hprt gene
expression (Table 1) is likely explained by
the Hprt minigene cassette used in the
selective elimination to disrupt the Cyp1a2
Toxicogenomics | Microarray analysis of the Cyp1a2(–/–) mouse
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Table 1. Hepatic genes signiﬁcantly expressed to a greater extent in Cyp1a2(–/–) compared with that in
Cyp1a2(+/+) mice.
Descriptiona Symbola Accession no.a Meanb SD
Hypoxanthine guanine phosphoribosyltransferase  Hprtb BF148132  5.38  1.80
Growth arrest and DNA-damage-inducible 45 gamma  Gadd45g  AI662702  3.16  1.06
Cytochrome P450, 2a4c Cyp2a4  AI118260  1.94  0.50
Major urinary protein-1  Mup1  AI225954  1.89  1.06
RIKEN cDNA 0610010A22 gene  0610010A22Rik  AA198519  1.85  0.52
Cytochrome P450, steroid inducible 3a11  Cyp3a11  AI255364  1.67  0.75
E4F transcription factor-1  E4f1  AA270628  1.65  0.76
Cytochrome P450, 7b1  Cyp7b1  AI287063  1.64  0.89
Glutathione S-transferase, pi 2  Gstp2  AA152555  1.59  0.46
Ferritin light chain-1  Ftl1  AA059749  1.61  0.70
NADPH-P450 (cytochrome) oxidoreductase  Por  BI144049  1.53  0.38
aFrom GenBank database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene). bRatio of expression in the
Cyp1a2(–/–) compared with that in the Cyp1a2(+/+) mouse. Results are means of ﬁve mice per line and signiﬁcantly dif-
ferent at p < 0.05. bThis may arise, in part or in total, from the HAT-selective minigene used for the selection of the trans-
fected ES cells. cAlso probably recognizing CYP2A5 cDNA and any other mouse CYP2A cDNA.
Table 2. Hepatic genes significantly expressed to a lower degree in Cyp1a2(–/–) compared with that in
Cyp1a2(+/+) mice.
Descriptiona Symbola Accession no.a Meanb SD
Cytochrome P450, 1a2, aromatic compound inducible  Cyp1a2  AA242360  <0.01  <0.01
Insulin-like growth factor binding protein-1  Igfbp1  W10866  0.12  0.08
G0/G1 switch gene-2  G0s2  NM_008059  0.20  0.09
Fatty acid synthase  Fasn  BF531259  0.27  0.15
Cytochrome P450, 4a14  Cyp4a14  AI893426  0.28  0.26
Stearoyl-coenzyme A desaturase-1  Scd1  AA269438  0.33  0.17
3-Hydroxy-3-methylglutaryl–coenzyme A reductase  Hmgcr  W18347  0.36  0.25
Glucokinase  Gk  AI194797  0.38  0.18
Fatty acid-binding protein 2, intestinal Fabp2  AA596309  0.40  0.09
Similar to tyrosine aminotransferase AA066836  0.41  0.22
Cytochrome P450, 4a10  Cyp4a10  AB018421  0.42  0.15
UDP-glucose ceramide glucosyltransferase  Ugcg  AA116263  0.45  0.28
Protein tyrosine phosphatase, nonreceptor type 16  Ptpn16  AI528560  0.45  0.37
Glutamyl aminopeptidase  Enpep  AA170635  0.45  0.33
Phosphoenolpyruvate carboxykinase-1, cytosolic  Pck1  AA063800  0.47  0.34
Pre-B-cell leukemia transcription factor 1  Pbx1  W85267  0.48  0.39
Apolipoprotein A-IV  Apoa4  AI385459  0.54  0.15
Serum amyloid P-component  Sap  AI157330  0.57  0.27
Pyruvate dehydrogenase E1alpha subunit  Pdha1  AW106750 0.58  0.19
Farnesyl diphosphate synthetase  Fdps  BE986882  0.58  0.25
Glutamate dehydrogenase  Glud  W09330 0.61 0.37
aFrom GenBank database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene). bRatio of expression in the
Cyp1a2(–/–) compared with that in the Cyp1a2(+/+) mouse. Results are means of ﬁve mice per line and signiﬁcantly dif-
ferent at p < 0.05.(Liang et al. 1996), or any other gene (van
der Lugt et al. 1991), in ES cells. The
Gadd45g gene, the Sprlc1 gene, and the
Cyp2a4/2a5 gene(s) were upregulated 3.2-,
2.4- and 1.9-fold, respectively. In addition
to the marked decrease in Cyp1a2 gene
expression (Table 2), as expected, several
other genes were downregulated by 2.5-
fold or more. These included the Igfbp1,
G0s2, Fasn, Cyp4a14, Scd1, Hmgcr, Gk and
Fabp2 genes. Recurrent functional themes
among both these up- and downregulated
genes include cell-cycle control, insulin
action, lipogenesis, and fatty acid and
cholesterol biosynthetic pathways.
Besides Cyp1a2, there were at least
three other mouse Cyp genes upregulated
(Table 1) and two others downregulated
(Table 2). We also documented in our
microarray that the expression of at least
nine other mouse Cyp genes was not signif-
icantly altered (Table 3). Expression of
genes encoding the AH receptor and both
forms of heme oxygenase was also not
signiﬁcantly changed (Table 3).
Reverse-transcription real-time PCR.
To prove the accuracy of the cDNA
microarray, we chose 15 of the genes that
had exhibited significant differences in
expression between the genotypes (in
Tables 1, 2) for further analysis by reverse-
transcription real-time PCR, and we used
Actb expression as a reference “housekeep-
ing” gene. For the 6 upregulated and the 9
downregulated genes investigated (Table 4), 
there was good agreement with those
changes that had been observed using the
cDNA arrays. The data in Table 4 thus
confirm the robustness of the cDNA
expression microarray approach.
Histology and morphometry. Conducting
histology on mouse liver several years ago,
it had independently been noted in one of
our laboratories that the lipid-containing
cells differ between Cyp1a2(–/–) and
Cyp1a2(+/+) mice (Figure 1). Morphometric
analysis of 28 Cyp1a2(–/–) and 28
Cyp1a2(+/+) mouse livers corroborated
that these lipid-storage differences are con-
sistent and statistically signiﬁcant (Table 5). 
The Vd of hepatic glycogen pools was
slightly but not significantly greater in the
Cyp1a2(–/–) mouse. The increase in
Cyp1a2(–/–) interstitial fat accounted for a
small increase in the Vd of interstitium
overall, which had a p value of 0.089. Total
lipid stores were significantly (p = 0.035)
decreased in the Cyp1a2(–/–) liver com-
pared with that in Cyp1a2(+/+) liver. This
decrease principally reﬂected a Vd of hepa-
tocyte-containing lipid droplets in
Cyp1a2(–/–) liver that was approximately
55% of that seen in Cyp1a2(+/+) liver. On
the other hand, there was a 45% increase
in the Vd of lipid found within the
Cyp1a2(–/–) interstitial fat-storing cells
compared with that in Cyp1a2(+/+) liver.
Gender influenced the response, with
females showing a greater increase than
males in fat stored in interstitial cells; in
retrospect, therefore, it might have been
worthwhile in the microarray experiments
to include comparisons between males
and females.
There were no signiﬁcant differences in
hepatocyte necrosis, inflammatory infil-
trate, binucleated hepatocytes, or number
of apoptotic hepatocytes that could be
attributed to the loss of CYP1A2. The
mitotic index in Cyp1a2(–/–) liver was
slightly elevated but not statistically signiﬁ-
cant compared with that in Cyp1a2(+/+)
liver (p = 0.16). 
Discussion
The data in this study strongly suggest that
mouse hepatic CYP1A2 is involved in a
number of previously unrecognized
endogenous functions. These findings are
in contrast to popular opinion that
CYP1A2 exists solely for the metabolism of
pharmaceuticals and other environmental
chemicals.
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Table 3. Hepatic Cyp and other possibly relevant genes whose expression is not significantly different
between the Cyp1a2(–/–) and Cyp1a2(+/+) mice.
Descriptiona Symbola Accession no.a Meanb SD
Cytochrome P450, 17  Cyp17  AA097768  0.80  0.19
Cytochrome P450, 2a12  Cyp2a12  AA255330  1.00  0.16
Cytochrome P450, 2b10, phenobarbital-inducible, type b  Cyp2b10  AI196037  1.02  0.20
Cytochrome P450, 2c29  Cyp2c29  AI529126  1.10  0.37
Cytochrome P450, 2d9  Cyp2d9  AA986388 0.94 0.15
Cytochrome P450, 2e1, ethanol-inducible  Cyp2e1  AA717630  0.92  0.43
Cytochrome P450, 2f2  Cyp2f2  AA242452  1.17  0.31
Cytochrome P450, 2j6  Cyp2j6  AI323934  0.72  0.21
Cytochrome P450, 3a25  Cyp3a25-pending  AA061713  1.15  0.37
Aryl-hydrocarbon receptor  Ahr  AA274836  1.19  0.37
Heme oxygenase (decycling)-1  Hmox1  W08092  1.30  0.16
Heme oxygenase (decycling)-2  Hmox2  AI428016  1.00  0.23
aFrom GenBank database (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene). bRatio of expression in the
Cyp1a2(–/–) compared with that in the Cyp1a2(+/+) mouse. Results are means of ﬁve mice per line and not signiﬁcantly
different (p > 0.05).
Table 4. Real-time PCR changes in expression of some hepatic genes in Cyp1a2(–/–) compared with that in Cyp1a2(+/+) mice.
Expression Meana SD  Forward primer  Reverse primer
Upregulation 
Gadd45g  4.26  2.57 GACCGCTGGCGTCTACGA GCACGCAAAAGGTCACATTGT
Cyp2a4/2a5 2.40  0.97 TCGAGGAGCGCATCCAA GACTGTTCGGCTAAGGTAGAAGGT
Mup1  1.72  0.58 GGGAAACCTTCCAGCTGATG  GGATTCCATGCTCCTCACATAGT
Cyp3a11  1.36  0.55 TTAAGAATGTGCTAGTGAAGGAATGTTT  CATCCTTAGATATTGAGATAGCTTTACTCATTA
Cyp7b1  1.42 0.54 GCTCTCGGCCCTGTTCCT GGGCCATGCCAAGATAAGG
Por  1.21  0.34 GCTGCAGGCCCGCTACTA  CGCAGATGTGCACGGAGTT
Downregulation
Igfbp1  0.09  0.05 CCATCAGCACCTATAGCAGCAT  ATTTGTAGATTTCATCTCCTGCTTTCT
G0s2  0.13  0.03 AACGCCAAAGCCAGTCTGA  CCTTGGCCAGAGGGATCA
Fasn  0.21  0.10 CATTGGTGGTGTGGACATGGT GACCGCTTGGGTAATCCATAGAG
Cyp4a14  0.11  0.12 CAAGACCCTCCAGCATTTCC  GCTCCCCGAGAGACACTGTAA
Scd1  0.24  0.10 CAACACCATGGCGTTCCA  GGTGGGCGCGGTGAT
Hmgcr  0.37  0.25 CGAGGAAAGACTGTGGTTTGTG  CGTCAACCATAGCTTCCGTAGTT
Gk  0.33  0.05 GCACACGTGGTGCTTTTGAG  GCCTTCGGTCCCCAGAGT
Fabp2  0.43  0.13 CCTAGAGACACACACAGCTGAGATC  CCAAGCTTCCTCTTCATCACATT
Pck1  0.53  0.27 TGTCGGAAGAGGACTTTGAGAAA  TGCTGAATGGGATGACATACATG
aRatio of expression in the Cyp1a2(–/–) compared with that in the Cyp1a2(+/+) mouse, relative to that of Actb (forward primer, GATTACTGCTCTGGCTCCTAGCA; reverse primer, GCCACC-
GATCCACACAGAGT). Results are means ± SD of three to four Cyp1a2(–/–) and three to four Cyp1a2(+/+) mice. Cell cycle control. The >3-fold upregu-
lation of the Gadd45g gene in Cyp1a2(–/–)
mice suggests there is some cellular stress
(Fornace et al. 1989), perhaps in genomic
stability, or alterations in cell cycle control
that might occur in the absence of
hepatic CYP1A2 constitutive expression;
GADD45γ is also associated with apoptosis
(Hollander et al. 2001), though this was
not reflected in an increase in apoptotic
hepatocytes. This marked increase in
Gadd45g expression could be related to dis-
ruption of the Cyp1a2 gene directly, or to
some secondary response caused by the
complete absence of CYP1A2 activity. It
might also be pertinent that there is a 
5-fold downregulation of the G0/G1
switch gene-2 (G0s2) (Table 2) and a 65%
increase in the E4F1 transcription factor
(E4f1) gene (Table 1), both involved in
cell-cycle regulation. Likely reasons for
CYP1A2 involvement in oxidative stress,
cell cycle control, and apoptosis have been
recently reviewed (Nebert et al. 2000b).
Histologically, however, the mitotic index
in the Cyp1a2(–/–) mice is only slightly
elevated (not statistically significant), and
the percent binucleated hepatocytes (which
reflects hepatocyte hypertrophy and
karyokinesis without cytokinesis) in
Cyp1a2(–/–) is almost identical to that in
the Cyp1a2 (+/+) wild type.
Insulin action, lipogenesis, and fatty
acid and cholesterol biosynthetic pathways.
Other than Cyp1a2, the gene exhibiting
apparently the greatest downregulation
was Igfbp1 (insulin-like growth factor
binding protein-1), which showed only
12% expression of that in the Cyp1a2(+/+)
wild-type mouse (Table 2). Again, this
may be linked to an overall downregula-
tion of cell proliferation or alterations in
lipid metabolism. The Igfbp1 promoter
shares common insulin regulatory response
elements with the phosphenolpyruvate
carboxykinase (Pck1) gene, which catalyzes
the rate-limiting and committed step in
gluconeogenesis, although different mech-
anisms are used by insulin to inhibit
expression of these two genes (Yeagley et
al. 2001). Pck1 was downregulated more
than 2-fold in the Cyp1a2(–/–) mouse
(Table 2). Interestingly, glucokinase,
another gene associated with insulin
action, was also downregulated. In hepato-
cytes, insulin stimulates a rapid increase in
transcription of the gene coding for sterol
response-binding protein-1c, which has
been implicated in the expression of
lipogenic genes; moreover, cholesterol syn-
thesis genes in hepatocytes include fatty
acid synthase (Fasn), steroyl-coenzyme A
desaturase (Scd1), 3-hydroxy-3-methylglu-
taryl-coenzyme A reductase (Hmgcr), 
glucokinase (Gk), and farnesyl diphosphate
synthase (Fdps) (Yeagley et al. 2001;
Joseph et al. 2002). The expression of
these ﬁve genes was signiﬁcantly decreased
in Cyp1a2(–/–) mouse liver (Table 2). The
1.6-fold increase in Cyp7b1 (Table 1), and
the downregulation of fatty acid-binding
protein-2 (Fabp2) and apolipoprotein A-
IV (Apoa4) (Table 2), provide further evi-
dence of the possible involvement of
CYP1A2 in fatty acid and cholesterol
pathways. This possible perturbation of
fatty acid and cholesterol pathways might
be reflected in the histologic assessment
(Table 5) in which the Cyp1a2(–/–) mouse
liver has less volume density of lipid
within its hepatocytes, concomitant with
increases in lipid in the fat-storing cells in
its interstitium compared with that in the
Cyp1a2(+/+) wild-type liver. 
Cyp gene expression. As expected, the
signal for Cyp1a2 gene expression was
markedly decreased by >99% in the
Cyp1a2(–/–) compared with that in the
Cyp1a2(+/+) mouse (Table 2). Since the
Cyp1a2 gene is constitutively quite highly
expressed in wild-type mice, it was of inter-
est to see whether there might be compen-
satory expression of any other CYP
enzymes. The upregulation of Cyp3a11
(Table 1) and the downregulation of
Cyp4a10 and Cyp4a14 (Table 2) might be
related to alterations in the arachidonic
acid cascade or other physiologic home-
ostasis (Nebert and Dieter 2000; Nebert
and Russell 2002) in the absence of
CYP1A2. The ESTs for each of the two
Cyp4a genes would have detected either
cDNA and, thus, these two could not be
properly distinguished––although differ-
ences in degree of upregulation were seen.
The greatest difference (1.94-fold
upregulation) was observed for Cyp2a4
(Table 1). Although this gene encodes
steroid 15α-hydroxylase in the synthesis of
testosterone and estradiol, both CYP2A4
and CYP2A5 have been shown to be mod-
ulated by circadian rhythm (Lavery et al.
1999; Akhtar et al. 2002). CYP2A5 has
coumarin 7-hydroxylase activity and meta-
bolically activates many chemicals such as
nitrosamines and aflatoxin that are known
hepatic carcinogens in mice (Negishi et al.
1989; Camus-Randon et al. 1996).
CYP2A5 induction differs from most
because it seems to occur by a variety of
agents, including not only drugs and chem-
icals such as pyrazole, phenobarbital and
cobalt but also viral and parasitic inflam-
mation and in hepatic neoplasia (Camus-
Randon et al. 1996; Wastl et al. 1998).
This often occurs under circumstances in
which other CYP isoforms are decreased.
Thus, it would seem that hepatic Cyp2a5
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Figure 1. Histology of mouse liver. Plastic sections (1-µ thick) of tissue were stained with toluidine blue to
show lipid droplets. (A) In the untreated Cyp1a2(–/–) knockout mouse, the number and size of tiny lipid
droplets in hepatocytes (black arrow) are greatly decreased, whereas the amount of large lipid droplets
in interstitial fat-storing cells (white arrows) is increased. (B) In the untreated Cyp1a2(+/+) wild-type
mouse, small osmiophilic lipid droplets (black arrows) are common in the hepatocytes, whereas larger
droplets occur occasionally in fat-storing cells of the interstitium (white arrow). Each bar is 25 µm.
Table 5. Intrahepatocyte versus interstitial fat in the liver of Cyp1a2(–/–) and Cyp1a2(+/+) mice.
Volume density (%)  Cyp1a2(–/–)  Cyp1a2(+/+)  p- value
Interstitium 11.0 ± 0.54  9.52 ± 0.47  0.089
Glycogen in hepatocytes 6.59 ± 1.0  5.37 ± 0.85  NS
Lipid in the whole liver 7.84 ± 1.08  12.1 ± 1.63  0.035
Hepatocyte lipid (in hepatocytes only)  6.38 ± 1.09  11.7 ± 1.72  0.012
Hepatocyte lipid in whole liver 5.72 ± 0.93  10.7 ± 1.58  0.009
Interstitial lipid (in interstitium cells only)  25.6 ± 2.29  17.6 ± 2.09  0.02
Interstitial lipid in whole liver 2.19 ± 0.23  1.35 ± 0.15  0.004
NS, not signiﬁcant. The morphometric data from 28 Cyp1a2(–/–) and 28 Cyp1a2(+/+) mice, studied in our laboratory for
more than 12 months from a number of different experiments, were combined to assess the intrahepatocyte versus inter-
stitial lipid stores.induction might be associated with a subtle
form of liver injury, although nothing was
seen histologically. Moreover, mouse
Cyp2a5 has been found to possibly be
involved in perturbation of the cell cycle
and apoptosis (Pelkonen 2002).
There was no signiﬁcant change in the
expression of heme oxygenase-1 (inducible
form) (Table 3), however, which is often
associated with CYP heme turnover and
oxidative stress. In addition, there was no
detectable elevation in the transcription of
Alas1, coding for 5-aminolevulinate syn-
thase, which can also occur in situations of
heme insufﬁciency (unpublished data). The
expression of nine other CYPs was detected
but was not signiﬁcantly different between
Cyp1a2(–/–) and Cyp1a2(+/+) mice (Table
3). Interestingly, this includes the Cyp2e1
gene, encoding an enzyme that is constitu-
tively quite highly expressed in mouse liver
and known to be induced by ethanol and
involved in small-molecule intermediary
metabolism, diabetes mellitus and ketosis,
as well as in the metabolism of drugs and
dietary components.
Hprt gene expression. The unexpected
observation that the Hprt gene is elevated
more than 5-fold (Table 1) can most likely
be explained by use of the Hprt minigene
cassette in the selective elimination of the
Cyp1a2 gene in ES cells (Liang et al. 1996).
In all probability, Hprt expression is being
driven by the nearby Cyp1a2 5´-flanking
regulatory region and promoter. We are
unable to conclude with certainty that
none of the changes observed (Tables 1, 2)
are the downstream consequence of this
striking elevation in Hprt expression.
Conclusions
In summary, absence of the mouse Cyp1a2
gene appears to lead to changes in expres-
sion of some genes related to cell growth as
well as to a downregulation of genes in
energy production mediated by insulin.
These endogenous functions would appear
to be separate from any activity involving
the metabolism of environmental chemicals.
It is possible that this Cyp1a2 gene knock-
out reflects a general disturbed metabolic
activity and an intrinsic function (Nebert
and Dieter 2000) of CYP1A2 in liver and
energy metabolism, which results in the
decreased ability of lipid to accumulate
within the hepatocyte cytoplasm. It is also
not possible at this stage to deduce if there is
any phenotypic consequence of Hprt over-
expression resulting from the use of this
gene in developing the knockout mouse
line. It will be easy enough in the near
future, however, to disrupt this Hprt selec-
tion gene and re-examine the Cyp1a2(–/–)
knockout mouse in the absence of Hprt.
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